Treatment

On this page

Clinical Trials & Research for this Disease

ClinicalTrials.gov lists trials that are studying or have studied Botulism. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies.

Medical Products

The medication(s) listed in the table(s) below have been approved by the Food and Drug Administration (FDA)
for treatment of this condition. The FDA Office of Orphan Products Development designates "orphan products"
for those that treat rare diseases affecting fewer than 200,000 Americans. The table(s) below may not be an exhaustive
list of drugs or products used to treat this condition. There may be other products available that are not considered
orphan products. To search for all FDA approved drugs, visit Drugs@FDA. You can find orphan products used to treat
other conditions by searching the Orphan Drug Product Designation database.

Generic Name

botulism antitoxin heptavalent (A, B, C, D, E, F, G) (Equine)

Indication
The FDA has approved this product to be used in this manner.